The Physio-Control Lifepak 15 defibrillator/monitor gives you more monitoring capabilities than any other defibrillator/monitor. The Lifepak 15 continuously monitors all 12-leads in the background and alerts the operator to any changes, gives EtCO2 with continuous waveform capture, and features Masimo Rainbow technology to help detect hard-to-diagnose conditions with noninvasive monitoring of carbon monoxide, SpO2, and methemoglobin. Using the CODE-STAT data review software, the Lifepak 15 allows the operator to transmit, trend, or display the recorded data for post-event review.
With more monitoring capabilities than any other monitor/defibrillator, the 15 gives you EtCO2 with continuous waveform capture. Masimo Rainbow technology helps you detect hard-to-diagnose conditions and improve patient care with noninvasive monitoring of carbon monoxide, SpO2, and methemoglobin. In addition, the 15 offers temperature monitoring—and like other data, you can transmit it to other systems, trend it, or display for post-event review in CODE-STAT data review software.
The 15 continuously monitors all 12 leads in the background and alerts you to changes using the ST-Segment trend monitoring feature, after acquiring the initial 12-lead. Additionally, STJ values are included on the 12-lead printout to help you identify changes. The 15 also works seamlessly with the web-based LIFENET System 5.0, so you can automatically share critical patient data with multiple patient care teams.
The LIFEPAK 15 monitor/defibrillator features 360J biphasic technology, which gives you the option of escalating your energy dose up to 360J for difficult-to-defibrillate patients. Why is this necessary? Recent studies have shown that refibrillation is common among VF cardiac arrest patients and that defibrillation of recurring episodes of VF is increasingly difficult. A randomized controlled clinical trial shows the rate of VF termination was higher with an escalating higher energy regimen of 200J and over.
The CPR Metronome in the Lifepak 15 monitor uses audible prompts to guide you without distracting vocal critique. A metronome has been a feature that has been demonstrated to help professionals perform compressions and ventilation within the recommended range of the 2015 AHA Guidelines. Post-event review of CPR data and delivering feedback to the team has been shown to be effective in improving CPR quality in both hospital and out-of-hospital.2,3,4 And by transmitting code data directly to CODE-STAT Data Review software, EMS personnel can review CPR statistics and provide training and feedback where it is most needed.
The device captures and stores patient data, events (including waveforms and annotations), and continuous waveform and patient impedance records in internal memory. The user can select and print reports, and transfer the stored information via supported communication methods
Report Types:
Memory Capacity:
The Physio Control Lifepak 15 is a complete monitor and defibrillator for acute cardiac care response. This system was designed for basic life support (BLS) and advanced life support (ALS). The Lifepak 15 defibrillator is intended for use by trained medical personnel in and out-of-doors and indoor emergency care settings. Manual mode monitoring and therapy functions are intended for use on adult and pediatric patients, and Automated external defibrillation mode is intended for use on patients eight years of age and older.
The Lifepak 15 operates only on battery power using two lithium-ion batteries, which must be removed from the device and charged in the Station or Mobile Li-ion Battery Charger. The batteries for the Lifepak 15 are not interchangeable with batteries that are used in other Lifepak defibrillators. Each battery has a fuel gauge that indicates the approximate charge level in the battery. If the battery only shows two or fewer LEDs immediately after completing a charge cycle, the battery should be replaced.
The electrocardiogram (ECG) is a recording of the electrical activity of the heart. ECG monitoring allows for the identification and interpretation of cardiac rhythms or dysrhythmias and calculation of heart rate. The ECG is obtained by place either electrodes or paddles on the patient and allows the heart's electrical activity to be monitored and recorded. ECG Monitoring is a tool to be used in addition to patient assessment. Care should be taken to assess the patient at all times; do not rely solely on the ECG monitor.
The 12-Lead ECG offers paramedics and emergency physicians significant advantages of the single lead ECG trace typically available in EMS. The 12-lead ECG not only provides a diagnostic quality ECG for use in the detection of ST elevation myocardial injury, anticipate associated potential complications, and implement treatment strategies accordingly. In addition, the 12-lead ECG provides a baseline for serial ECG evaluations. The 12-Lead ECG transmission to the emergency department (ED) is recommended by the AHA and ERC for patients with Acute Coronary Syndrome (ACS). When transmitted from the field, 12-Lead ECG has been shown to shorten time to in-hospital treatment by an estimated 10 to 60 minutes. Patients may also benefit from triage and transport to the most appropriate facility. Documentation of transient or intermittent arrhythmias and other electrophysiologic events that offer in the prehospital setting can assist in diagnosis and treatment decision in the ED.
Computerized ECG analysis statements are automatically printed on 12-lead ECG reports. Printing of the interpretive statements is a setup option and may be turned off in Setup mode. These statements pertaining to myocardial injury, infarct, and ischemia are derived from measurements made on a signal-average beat (median beat) formed for each of the 12 leads. The analysis program is adjusted for patient age and sex. The University of Glasgow 12-Lead ECG analysis Program is used on the Lifepak 15.
SpO2, SpCO, and SpMet are optional features for the Lifepak 15 monitor.defibrillator. When all three options are installed, the pulse oximeter measures functional oxygen saturation, carboxyhemoglobin concentration, and methemoglobin concentration in the blood. SpO2-only sensors and combination SpO2, SpCO, and SpMet sensors are available for this unit.
The pulse oximeter is a noninvasive device that continuously measures functional oxygen saturation (SpO2), carboxyhemoglobin concentration (SpCO, and methemoglobin concentration (SpMet) in the blood. Continuously monitoring SpO2 can provide an early warning when oxygen saturation is decreasing and can help the clinician act rapidly before the patient develops the later signs of hypoxemia. Previously, the blood parameters SpCO and SpMet could only be obtained from invasive blood gas samples. This new technology assists in identifying the often hidden conditions of carboxyhemoglobinemia (carbon monoxide poisoning) and methemoglobinemia (a condition that impedes delivery of oxygen to the tissues). Low levels of both SpCO and SpMet are normally found in the blood; however, early detection of significantly high levels can lead to proper diagnosis and treatment and can help improve patient outcome.